| Literature DB >> 32393429 |
Meng-Jiao Du1, Jian-Ping Chen2, Bo-Wen Lian3, Wen-Jie Mei4, Jia-Xian Yu5, Li-Shi Chen1, Shan-Bin Deng1, Yan-Mei Zhong6, Chu-Qin Yu7.
Abstract
Timosaponin B-II (TB-II; (25S)-26-(β-D-glucopyranosyloxy)-3β-[(2-O-β-D-glucopyranosyl-β-D-galactopyranosyl) oxy]-5β-furostan-22-ol is extracted from Anemarrhena. Its anti-inflammation, anti-oxidation, and anti-asthma properties have been widely explored. However, its effect on the heart has not been reported. In this study, we used zebrafish as a research model to determine the effects of TB-II on the heart and its toxic and anti-inflammatory effects. To explore the cause of cardioprotective effects of TB-II, we used transgenic zebrafish with macrophages and neutrophils labeled with fluorescent protein. We found for the first time that TB-II had a protective effect on the zebrafish heart. It did not affect the survival and hatching rates of zebrafish embryos, indicating its low toxicity. Results showed that TB-II may have cardioprotective effects, which might be related to its anti-inflammatory effects.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32393429 DOI: 10.1691/ph.2020.9869
Source DB: PubMed Journal: Pharmazie ISSN: 0031-7144 Impact factor: 1.267